NIH plans to begin AIDS drug trials at earlier stage

Article Abstract:

Recent findings have determined that the human immunodeficiency virus (HIV) is active in the body in larger numbers much earlier than previously thought. As a result, the National Institutes of Health (NIH) is planning to institute new policies geared toward earlier treatment of AIDS. AIDS activists welcomed the new findings, although they stated that the scientific community had been slow in elucidating the pathogenesis of the disease. However, Peter Duesberg, the main proponent of the idea that AIDS is not caused by HIV, remains unconvinced by the new findings.

Research, Social policy, HIV (Viruses), HIV, Interview

---

Dispute over money may foil US AIDS vaccines trial

Article Abstract:

The US National Institutes of Health (NIH) cannot afford to pay $10 million to Micro Genesys, the connecticut company which is the only US producer of gp-160, one of the three therapeutic AIDS vaccines. Frank Volvovtiz, president of Microgenesys insists on the payment before their company provides them with the vaccine. This dispute would lead to the collapse of an agreement between the US National Institutes of Health (NIH) and the Department of Defence (DOD) to test therapeutic AIDS vaccines.

Economic aspects

---

Physicians not fazed by AZT guidelines

Article Abstract:

An expert panel has counselled doctors to discuss with their patients and use their discretion before prescribing antiretroviral drugs, such as AZT, to HIV carriers. Doctors should consider an individual's needs and personal life style when prescribing AZT for patients with low CD4 counts. A national commission on AIDS criticized government officials and religious and community heads for taking inadequate measures to curb AIDS.

Drug use, Antiviral agents

Similar abstracts:

• Abstracts: India finally agrees to trials. India moves ahead cautiously on US AIDS project. Johns Hopkins embroiled in fresh misconduct allegations
• Abstracts: NIH launches surprise Gallo investigation. AIDS dispute: time not right for Gallo. Assumptions of AIDS inquiry challenged
• Abstracts: Lead isotope evidence for young trace element enrichment in the oceanic upper mantle. Inside the cosmic blender
• Abstracts: SERC broadens its role in support of industry. 'Foresight' panel urges new priorities for life sciences. Bidding to manage North Sea data raises questions about privatisation
• Abstracts: Singapore plans to double research cash. Japanese stimulus package includes billions for computers. Research spending is almost flat for leading Japanese companies

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.